Company Filing History:
Years Active: 2007-2012
Title: Innovations in Tuberculosis Detection by Konstantin Lyashchenko
Introduction
Konstantin Lyashchenko is an accomplished inventor based in East Setauket, NY (US). He has made significant contributions to the field of diagnostic methods for tuberculosis (TB) detection. With a total of two patents to his name, his work focuses on improving the accuracy and efficiency of TB testing in various species.
Latest Patents
Lyashchenko's latest patents include an "Assay for detecting tuberculosis in nonhuman primates" and a "Universal rapid test and method for detection of tuberculosis in multiple host species." The first patent describes a diagnostic method that utilizes recombinant mycobacterial antigens, such as polyfusion proteins, to detect TB infection in nonhuman primates. This method is designed to be user-friendly, sensitive, and specific, allowing for the detection of both IgM and IgG antibodies to TB, which enables earlier detection compared to conventional tests. The second patent presents a universal test apparatus that can detect TB in various non-primate mammals. This apparatus includes a mycobacterial antigen cocktail and a tracer conjugated to latex or colloidal gold, making it effective across different genera, families, and orders of mammals.
Career Highlights
Konstantin Lyashchenko is currently associated with Chembio Diagnostic Systems, Inc., where he continues to innovate in the field of diagnostics. His work has been pivotal in advancing the methodologies used for TB detection, contributing to better health outcomes in both human and animal populations.
Collaborations
Lyashchenko has collaborated with notable colleagues, including Javanbakhsh Esfandiari and Candace McCombs. These collaborations have further enhanced the research and development of effective diagnostic tools for tuberculosis.
Conclusion
Konstantin Lyashchenko's contributions to tuberculosis detection represent a significant advancement in medical diagnostics. His innovative patents and ongoing work at Chembio Diagnostic Systems, Inc. continue to pave the way for improved health solutions.